Lucky James L 4
4 · AtriCure, Inc. · Filed Mar 7, 2013
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Lucky James L
VP, Regulatory Affairs and QA
Transactions
- Exercise/Conversion
Common Stock
2013-03-05$6.34/sh+13,949$88,437→ 60,342 total - Sale
Common Stock
2013-03-05$8.13/sh−13,949$113,405→ 46,393 total - Exercise/Conversion
Common Stock
2013-03-05$5.60/sh+31,500$176,400→ 77,893 total - Sale
Common Stock
2013-03-05$8.13/sh−31,500$256,095→ 46,393 total - Exercise/Conversion
Common Stock
2013-03-05$1.52/sh+9,473$14,399→ 55,866 total - Sale
Common Stock
2013-03-06$8.22/sh−616$5,064→ 55,250 total - Sale
Common Stock
2013-03-06$8.22/sh−4,000$32,880→ 51,250 total - Exercise/Conversion
Stock Option (right to buy)
2013-03-05−13,949→ 156,051 totalExercise: $6.34From: 2007-09-06Exp: 2016-09-06→ Common Stock (13,949 underlying) - Exercise/Conversion
Stock Option (right to buy)
2013-03-05−31,500→ 124,551 totalExercise: $5.60From: 2011-02-17Exp: 2020-02-17→ Common Stock (31,500 underlying) - Exercise/Conversion
Stock Option (right to buy)
2013-03-05−9,473→ 115,078 totalExercise: $1.52From: 2005-01-01Exp: 2014-01-01→ Common Stock (9,473 underlying)
Footnotes (5)
- [F1]This transaction was executed in multiple trades at prices ranging from $8.00 to $8.33 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $8.21 to $8.24 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]These options were granted on September 6, 2006 and vest and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vest and is exercisable in equal monthly installments on the same day of the month over the following three years.
- [F4]These options were granted on February 17, 2010 and vest and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
- [F5]These options were granted on January 1, 2004 and are exercisable cumulatively at a rate of 25% per annum beginning one year from the date of grant date.